A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Phendimetrazine
Aceclofenac
Potassium may increase the excretion rate of Aceclofenac which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Clevidipine
Potassium may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.
Phendimetrazine
Sulfate ion
The risk or severity of adverse effects can be increased when Potassium is combined with Sulfate ion.
Phendimetrazine
Dehydrocholic acid
The risk or severity of adverse effects can be increased when Potassium is combined with Dehydrocholic acid.
Phendimetrazine
Frangula purshiana bark
The risk or severity of adverse effects can be increased when Potassium is combined with Frangula purshiana bark.
Phendimetrazine
Alloin
The risk or severity of adverse effects can be increased when Potassium is combined with Alloin.
Phendimetrazine
Konjac mannan
The risk or severity of adverse effects can be increased when Potassium is combined with Konjac mannan.
Phendimetrazine
Calcium polycarbophil
The risk or severity of adverse effects can be increased when Potassium is combined with Calcium polycarbophil.
Phendimetrazine
Oxyphenisatin acetate
The risk or severity of adverse effects can be increased when Potassium is combined with Oxyphenisatin acetate.
Phendimetrazine
Plantago ovata seed
The risk or severity of adverse effects can be increased when Potassium is combined with Plantago ovata seed.
Phendimetrazine
Sodium cation
The risk or severity of adverse effects can be increased when Potassium is combined with Sodium cation.
Phendimetrazine
Sodium phosphate, dibasic, unspecified form
The risk or severity of adverse effects can be increased when Potassium is combined with Sodium phosphate, dibasic, unspecified form.
Phendimetrazine
Sodium phosphate, monobasic, unspecified form
The risk or severity of adverse effects can be increased when Potassium is combined with Sodium phosphate, monobasic, unspecified form.
Phendimetrazine
Potassium sulfate
The risk or severity of adverse effects can be increased when Potassium is combined with Potassium sulfate.
Phendimetrazine
Sodium ascorbate
The risk or severity of adverse effects can be increased when Potassium is combined with Sodium ascorbate.
Phendimetrazine
Deacetylbisacodyl
The risk or severity of adverse effects can be increased when Potassium is combined with Deacetylbisacodyl.
Phendimetrazine
Magnesium acetate
The risk or severity of adverse effects can be increased when Potassium is combined with Magnesium acetate.
Phendimetrazine
Sodium tartrate
The risk or severity of adverse effects can be increased when Potassium is combined with Sodium tartrate.
Phendimetrazine
Pentaerithrityl
The risk or severity of adverse effects can be increased when Potassium is combined with Pentaerithrityl.
Phendimetrazine
Magnesium peroxide
The risk or severity of adverse effects can be increased when Potassium is combined with Magnesium peroxide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3